How long does CBD take to kick in? From 3 min to 5 h

The most cited reference is a systematic review published in 2018 in Frontiers in Pharmacology. Its authors, Millar and colleagues, kept 24 publications out of 792 that reported pharmacokinetic data in humans. Pharmacokinetics describes the journey of a molecule through the body: absorption, blood peak, elimination.

The number that answers "how long" is called Tmax: the time between intake and the highest blood concentration. It is not the time to a felt effect, which these studies do not measure. The same review notes that no study has measured the absolute bioavailability of swallowed CBD in humans, that is, the share that actually reaches the blood. The only known value concerns smoking: 31%.

Inhalation is the fastest route: after a cigarette containing 19.2 mg of CBD, the blood peak was recorded 3 minutes after intake. Smoking burns plant matter, though, and produces toxic compounds; our article on vaporisation temperatures explains what changes without combustion.

For oil held under the tongue, the data come mainly from Sativex sprays, applied inside the cheek or under the tongue. Their means range from 1 hour to 4.6 hours depending on the trial. Our guide to the sublingual method describes the technique and its limits.

Swallowed CBD passes through the liver before reaching general circulation, which delays and lowers the peak. In the trial by Taylor and colleagues on an oral solution, Tmax was about 4 to 5 hours. For cosmetics applied to the skin, the 2018 review lists no human pharmacokinetic data.

CBD dissolves in fat, not in water. In the phase I trial published in 2018 in CNS Drugs, a high-fat meal multiplied the blood peak by 4.85 and total exposure by 4.2, without changing Tmax.

Another trial cited by Millar found a similar effect with the mouth spray: exposure multiplied by 5 and the peak by 3 after a meal, but with Tmax delayed from 1.4 to 4.0 hours. The practical upshot: if you compare two days of use, compare them under the same meal conditions.

Half-life is the time it takes for the blood concentration to fall by half. For CBD it depends heavily on the route and on repeated dosing:

• Mouth spray, single dose: 1.4 to 10.9 hours.
• Oral route, repeated doses: 2 to 5 days, according to an older six-week study.
• Oral solution twice a day: terminal half-life of about 60 hours and "effective" half-life of 10 to 17 hours in the 2018 trial.

The same trial observed a steady state, where blood levels stop rising from one dose to the next, after about 2 days of morning and evening doses. CBD then builds up moderately, 1.8 to 2.6-fold. These measurements used doses of 750 and 1,500 mg, far above those of a shop oil: the order of magnitude holds, not the exact figures.

Many brands advise waiting four to six weeks before judging a product. That benchmark comes from neither the ANSM nor the HAS, France's medicines and health technology agencies. Pharmacokinetics does not require it either, since blood levels stabilise within a few days. It mainly smooths out day-to-day variation in subjective measures, such as how rested you feel.

If you want an honest picture, set the frame before you start:

1. One product and one route, for example a CBD oil always used the same way.
2. A stable dose and time of day, under the same meal conditions.
3. A few lines of notes each day: time, amount, what you notice in the following hours, a score from 1 to 10 the next day.
4. No other change at the same time: no new supplement, no break in your sleep schedule.

At the end of the period, three readings are possible. A clear, repeated trend; no difference, which is a valid answer; or recurring side effects, such as drowsiness or digestive upset, which are a reason to stop. Self-assessment has a known limit: it cannot separate the product's effect from the placebo effect or the ritual. Doubling the dose to "feel something" mainly raises the risk of side effects.

Feeling nothing is common and not abnormal. The real dose may be low, the route inefficient, or the product weaker than its label: check the certificate of analysis for the batch, which our laboratory page explains how to read. Our article on why you might feel nothing with CBD goes through these leads, and the one on EFSA's reference dose gives quantity benchmarks.

No CBD product sold in shops may claim a therapeutic effect, the French drug policy agency MILDECA reminds sellers, on pain of criminal penalties. The only authorised medicine based on cannabidiol is Epidyolex, prescribed for rare epilepsies.

CBD meant to be swallowed falls under the EU novel food regulation. In a notice published on 20 May 2026, the French Ministry of Agriculture states that foods and food supplements containing CBD are not authorised, and announces checks. Our overview of CBD regulation in 2026 details the situation.

EFSA set on 9 February 2026 a provisional safe intake of 0.0275 mg per kilo per day, about 2 mg for a 70 kg adult. It adds that safety is not established under the age of 25, during pregnancy or breastfeeding, or for people taking medication. France's food safety agency Anses also proposed on 21 March 2025 to classify CBD as presumed toxic for reproduction. If you take any medicine, talk to your doctor: CBD goes through the liver enzymes CYP3A4 and CYP2C19, like many drugs, as our article on CBD drug interactions describes.